SciClone Pharmaceuticals (Holdings) Limited (SCCPF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 01:32PM EDT
| Previous Close | 0.8301 |
| Open | 0.8301 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.8301 - 0.8301 |
| 52 Week Range | 0.8301 - 0.8301 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | 746.92M |
| Beta (5Y Monthly) | 0.82 |
| PE Ratio (TTM) | 4.37 |
| EPS (TTM) | 0.1900 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Jun 02, 2023 |
| 1y Target Est | N/A |
Business WireMenarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer
FLORENCE, Italy & HONG KONG, November 07, 2023--The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and SciClone Pharmaceuticals (Holdings) Ltd. ("SciClone"), an international biopharmaceutical company, today announced that they have entered into an exclusive sub-licensing agreement to develop and commercialize ORSERDU® (elacestrant) in the People’s Republic of China (China), in an effort to expand treatment options for appropriate metastatic breast c
© 2024 Yahoo. All rights reserved.